Correlation Between Pyxis Oncology and ZyVersa Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyxis Oncology and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyxis Oncology and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyxis Oncology and ZyVersa Therapeutics, you can compare the effects of market volatilities on Pyxis Oncology and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyxis Oncology with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyxis Oncology and ZyVersa Therapeutics.

Diversification Opportunities for Pyxis Oncology and ZyVersa Therapeutics

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pyxis and ZyVersa is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Pyxis Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyxis Oncology are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Pyxis Oncology i.e., Pyxis Oncology and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Pyxis Oncology and ZyVersa Therapeutics

Given the investment horizon of 90 days Pyxis Oncology is expected to generate 0.82 times more return on investment than ZyVersa Therapeutics. However, Pyxis Oncology is 1.22 times less risky than ZyVersa Therapeutics. It trades about -0.15 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  361.00  in Pyxis Oncology on August 24, 2024 and sell it today you would lose (151.00) from holding Pyxis Oncology or give up 41.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pyxis Oncology  vs.  ZyVersa Therapeutics

 Performance 
       Timeline  
Pyxis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pyxis Oncology and ZyVersa Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyxis Oncology and ZyVersa Therapeutics

The main advantage of trading using opposite Pyxis Oncology and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyxis Oncology position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.
The idea behind Pyxis Oncology and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope